secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001437749-26-004245
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals files $20M ATM offering for common stock
------------------------------------------------------------

- Filed prospectus supplement for up to $20M of common stock via ATM with H.C. Wainwright & Co.
- Shares to be issued under S-3 registration statement declared effective December 22, 2025.
- Legal opinion from Cozen O'Connor on share validity filed as Exhibit 5.1.
- No specific sales, pricing, or use of proceeds disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/0001437749-26-004245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/nrxp20260216_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer